Ancilia Biosciences

🗓 Founded 2019👥 18 employees💰 Last funded 2024
Biotechnology🌐 anciliabio.com
Website LinkedIn
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Investor activity2020–2024 · investors recorded per year
2020220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ancilia Biosciences?
Ancilia Biosciences has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Ancilia Biosciences last raise funding?
The most recent investment in Ancilia Biosciences recorded on gritt.io was in 2024.
When was Ancilia Biosciences founded?
Ancilia Biosciences was founded in 2019.
What industry is Ancilia Biosciences in?
Ancilia Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.